Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › APO-T And LinXis Announce Antibody Drug Conjugate Option To In-License Agreement

 

APO-T And LinXis Announce Antibody Drug Conjugate Option To In-License Agreement

2013-03-22 09:08:00| drugdiscoveryonline News Articles

APO-T B.V. and LinXis B.V., both privately owned oncology companies, announced recently that LinXis has granted APO-T an exclusive worldwide license for the development and commercialization of fully-human antibody-drug-conjugates using APO-T’s MAGE-HLA targeted antibodies and LinXis’ unique LX linker technology

Tags: agreement option drug announce

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

18.05 Unpaid carers being forced to repay 250m to DWP 18.05 Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 17.05 House Republicans release farm bill draft 17.05 House Republicans release farm bill draft More »